CRESCITA THERAPEUTICS INC (CTX.CA) Stock Price, Forecast & Analysis
TSX:CTX • CA2258471028
CTX.CA Key Statistics, Chart & Performance
The current stock price of CTX.CA is 0.48 CAD. In the past month the price decreased by -1.03%. In the past year, price decreased by -15.79%.
CTX.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CTX.CA. When comparing the yearly performance of all stocks, CTX.CA is a bad performer in the overall market: 83.23% of all stocks are doing better.
CTX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CTX.CA. While CTX.CA has a great health rating, there are worries on its profitability.
CTX.CA Financial Highlights
Over the last trailing twelve months CTX.CA reported a non-GAAP Earnings per Share(EPS) of 0.02. The EPS increased by 117.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.07% | ||
| ROA | 2.13% | ||
| ROE | 2.81% | ||
| Debt/Equity | 0 |
CTX.CA Forecast & Estimates
CTX.CA Ownership
CTX.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.39 | 3.019B | ||
| CRON | CRONOS GROUP INC | 36.99 | 1.372B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.213B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.31 | 923.524M | ||
| DHT-U | DRI HEALTHCARE TRUST | 5.43 | 686.119M | ||
| GUD | KNIGHT THERAPEUTICS INC | 132.15 | 625.948M | ||
| WEED | CANOPY GROWTH CORP | N/A | 597.979M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 458.223M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 28.02 | 381.475M | ||
| TSND | TERRASCEND CORP | N/A | 304.466M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About CTX.CA
Company Profile
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Laval, Quebec and currently employs 75 full-time employees. The company went IPO on 2016-03-07. The company offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The company operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. The company also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment is engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. The Manufacturing and Services segment is engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.
Company Info
CRESCITA THERAPEUTICS INC
2805, Place Louis R Renaud
Laval QUEBEC H7V 0A3 CA
CEO: Serge Verreault
Employees: 75
Phone: 18003610352
CRESCITA THERAPEUTICS INC / CTX.CA FAQ
What does CRESCITA THERAPEUTICS INC do?
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Laval, Quebec and currently employs 75 full-time employees. The company went IPO on 2016-03-07. The company offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The company operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. The company also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment is engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. The Manufacturing and Services segment is engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.
What is the stock price of CRESCITA THERAPEUTICS INC today?
The current stock price of CTX.CA is 0.48 CAD. The price increased by 2.13% in the last trading session.
Does CRESCITA THERAPEUTICS INC pay dividends?
CTX.CA does not pay a dividend.
How is the ChartMill rating for CRESCITA THERAPEUTICS INC?
CTX.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the GICS sector and industry of CTX stock?
CRESCITA THERAPEUTICS INC (CTX.CA) operates in the Health Care sector and the Pharmaceuticals industry.
What is the market capitalization of CTX stock?
CRESCITA THERAPEUTICS INC (CTX.CA) has a market capitalization of 8.93M CAD. This makes CTX.CA a Nano Cap stock.
Can you provide the upcoming earnings date for CRESCITA THERAPEUTICS INC?
CRESCITA THERAPEUTICS INC (CTX.CA) will report earnings on 2026-03-25.